Heleen Bouman

5.0k citations

31 papers · 2.2k indexed · 1 hit paper · h-index 19

Cardiology and Cardiovascular Medicine top 1%
Surgery top 5%
Internal Medicine top 0.5%
Endocrinology, Diabetes and Metabolism top 2%
Pharmacology top 2%

Co-authors: Jochem W. van Werkum Jurriën M. ten Berg Nicoline J. Breet Christian M. Hackeng Ankie M. Harmsze Vera H.M. Deneer C. M. Hackeng Dirk Taubert
Topics: Antiplatelet Therapy and Cardiovascular Diseases (24 papers)Atrial Fibrillation Management and Outcomes (10 papers)Coronary Interventions and Diagnostics (9 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism
Journals: JAMA Nature Medicine Journal of the American College of Cardiology
Partner nations: Netherlands Germany United States

In The Last Decade

Heleen Bouman

31 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

2010 636 citations Nicoline J. Breet, Jochem W. van Werkum et al. profile →

Peers

Countries citing papers authored by Heleen Bouman

Since Specialization

Citations

This map shows the geographic impact of Heleen Bouman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heleen Bouman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heleen Bouman more than expected).

Fields of papers citing papers by Heleen Bouman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heleen Bouman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heleen Bouman. The network helps show where Heleen Bouman may publish in the future.

Co-authorship network of co-authors of Heleen Bouman

This figure shows the co-authorship network connecting the top 25 collaborators of Heleen Bouman. A scholar is included among the top collaborators of Heleen Bouman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heleen Bouman. Heleen Bouman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of dialysate calcium prescription on mortality outcomes in incident patients on hemodialysis 2024 ·Clinical Kidney Journal ·(unknown),Paola Carioni,Francesco Bellocchio,Frank M. van der Sande,Heleen Bouman,Stefano Stuard,Luca Neri,Jeroen P. Kooman	2
2	Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients 2016 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Minka J. A. Vries,Heleen Bouman,Renske H. Olie,Leo Veenstra,(unknown),Paul Verhezen,Arina J. ten Cate‐Hoek,Hugo Ten Cate,Yvonne Henskens,Paola E. J. van der Meijden	22
3	The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting 2014 ·Thrombosis and Haemostasis ·Nicoline J. Breet,(unknown),Willem Jan W. Bos,(unknown),Heleen Bouman,Johannes C. Kelder,Thomas O. Bergmeijer,Felix Zijlstra,Christian M. Hackeng,Jurriën M. ten Berg	22
4	The influence of CYP2C192 and 17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting 2012 ·Pharmacogenetics and Genomics ·Ankie M. Harmsze,Jochem W. van Werkum,Christian M. Hackeng,Hendrik J.T. Ruven,Johannes C. Kelder,Heleen Bouman,Nicoline J. Breet,Jurriën M. ten Berg,Olaf H. Klungel,Anthonius de Boer,Vera H.M. Deneer	64
5	High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention 2011 ·Heart ·Nicoline J. Breet,Jochem W. van Werkum,Heleen Bouman,Johannes C. Kelder,Ankie M. Harmsze,C. M. Hackeng,Jurrien M. ten Berg	60
6	A case–control study on platelet reactivity in patients with coronary stent thrombosis 2011 ·Journal of Thrombosis and Haemostasis ·Heleen Bouman,Jochem W. van Werkum,Nicoline J. Breet,Hugo Ten Cate,C. M. Hackeng,Jurriën M. ten Berg	18
7	Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C192 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention 2011 ·Journal of Thrombosis and Haemostasis* ·Ankie M. Harmsze,Jochem W. van Werkum,Patrick C. Souverein,Nicoline J. Breet,Heleen Bouman,C. M. Hackeng,Henk J.T. Ruven,Jurriën M. ten Berg,Olaf H. Klungel,Anthonius de Boer,Vera H.M. Deneer	37
8	Effect of gender difference on platelet reactivity 2011 ·Netherlands Heart Journal ·Nicoline J. Breet,Maayke A. Sluman,(unknown),Jochem W. van Werkum,Heleen Bouman,Ankie M. Harmsze,Johannes C. Kelder,Felix Zijlstra,C. M. Hackeng,Jurriën M. ten Berg	66
9	The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction 2011 ·Thrombosis and Haemostasis ·Nicoline J. Breet,Jochem W. van Werkum,Heleen Bouman,Johannes C. Kelder,Christian M. Hackeng,Jurriën M. ten Berg	14
10	Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk? 2011 ·Netherlands Heart Journal ·Nicoline J. Breet,(unknown),Jochem W. van Werkum,Heleen Bouman,Johannes C. Kelder,Felix Zijlstra,C. M. Hackeng,Jurriën M. ten Berg	19
11	Reply to: "Paraoxonase-1 and clopidogrel efficacy" 2011 ·Nature Medicine ·Heleen Bouman,Edgar Schömig,Jochem W. van Werkum,Janna Velder,Christian M. Hackeng,Christoph Hirschhäuser,Christopher M. Waldmann,Hans‐Günther Schmalz,Jurriën M. ten Berg,Dirk Taubert	6
12	Platelet function tests for the monitoring of P2Y12 inhibitors 2010 ·Expert Opinion on Medical Diagnostics ·Nicoline J. Breet,Jochem W. van Werkum,Heleen Bouman,Jurriën M. ten Berg,Christian M. Hackeng	1
13	CYP2C192 and CYP2C93 alleles are associated with stent thrombosis: a case-control study 2010 ·European Heart Journal ·Ankie M. Harmsze,Jochem W. van Werkum,Jurriën M. ten Berg,Bastiaan Zwart,Heleen Bouman,Nicoline J. Breet,Arnoud W.J. van ‘t Hof,Henk J.T. Ruven,C. M. Hackeng,Olaf H. Klungel,Anthonius de Boer,Vera H.M. Deneer	117
14	Paraoxonase-1 is a major determinant of clopidogrel efficacy 2010 ·Nature Medicine ·Heleen Bouman,Edgar Schömig,Jochem W. van Werkum,Janna Velder,Christian M. Hackeng,Christoph Hirschhäuser,Christopher M. Waldmann,Hans‐Günther Schmalz,Jurriën M. ten Berg,Dirk Taubert	356
15	High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events 2010 ·Journal of Thrombosis and Haemostasis ·Nicoline J. Breet,Jochem W. van Werkum,Heleen Bouman,Johannes C. Kelder,Jurriën M. ten Berg,C. M. Hackeng	67
16	The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: A comparison with the flowcytometric VASP assay and optical aggregometry 2010 ·Thrombosis Research ·Jochem W. van Werkum,Heleen Bouman,Nicoline J. Breet,Jurriën M. ten Berg,Christian M. Hackeng	18
17	Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects 2009 ·Netherlands Heart Journal ·Heleen Bouman,Jochem W. van Werkum,C. M. Hackeng,(unknown),J M Ten Berg	13
18	Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel 2009 ·Journal of Thrombosis and Haemostasis ·Heleen Bouman,(unknown),Jochem W. van Werkum,Nicoline J. Breet,Hugo Ten Cate,C. M. Hackeng,Jurriën M. ten Berg,Dirk Taubert	87
19	The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests 2009 ·Thrombosis and Haemostasis ·(unknown),(unknown),(unknown),Heleen Bouman,Freek W.A. Verheugt,Jurriën M. ten Berg,Christian M. Hackeng,Jochem W. van Werkum	74
20	Synthesis and properties of alkyldicyclopentadienyl-vanadium(III) compounds 1976 ·Journal of Organometallic Chemistry ·Heleen Bouman,Jan H. Teuben	18

About Heleen Bouman

Heleen Bouman is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 31 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Coronary Interventions and Diagnostics (9 papers). The work is most often cited by research in Internal Medicine (569 citations), Cardiology and Cardiovascular Medicine (1.9k citations) and Endocrinology, Diabetes and Metabolism (453 citations). Heleen Bouman has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Jochem W. van Werkum, Jurriën M. ten Berg, Nicoline J. Breet, Christian M. Hackeng, Ankie M. Harmsze, Vera H.M. Deneer, C. M. Hackeng, Dirk Taubert, Henk J.T. Ruven and Johannes C. Kelder. Their work appears in journals such as JAMA, Nature Medicine and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact